3-47577101-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006574.4(CSPG5):āc.925C>Gā(p.Leu309Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006574.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSPG5 | NM_006574.4 | c.925C>G | p.Leu309Val | missense_variant | 2/5 | ENST00000264723.9 | NP_006565.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSPG5 | ENST00000264723.9 | c.925C>G | p.Leu309Val | missense_variant | 2/5 | 1 | NM_006574.4 | ENSP00000264723.4 | ||
CSPG5 | ENST00000383738.6 | c.925C>G | p.Leu309Val | missense_variant | 2/5 | 1 | ENSP00000373244.2 | |||
CSPG5 | ENST00000456150.5 | c.511C>G | p.Leu171Val | missense_variant | 1/4 | 1 | ENSP00000392096.1 | |||
CSPG5 | ENST00000610462.1 | c.925C>G | p.Leu309Val | missense_variant | 2/4 | 5 | ENSP00000478923.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2022 | The c.925C>G (p.L309V) alteration is located in exon 2 (coding exon 2) of the CSPG5 gene. This alteration results from a C to G substitution at nucleotide position 925, causing the leucine (L) at amino acid position 309 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at